Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00017628

Locations


United States, Illinois
	Northwestern Memorial Hospital
	Chicago, Illinois, United States, 60611
	Rush-Presbyterian-St. Luke's Medical Center
	Chicago, Illinois, United States, 60612

Sponsors and Collaborators

Northwestern Memorial Hospital

Investigators


Study Chair:	Richard K. Burt	Northwestern Memorial Hospital